Healthcare

On 2 October 2026, Neuren shares were trading at $20.28, up 0.70%. The company reports on a calendar-year basis, and its half-year results to 30 June 2026 introduced its firstDividendpolicy.

On 2 October 2026, Pro Medicus shares were trading at $156.38, down 2.92%. The company's full-year results, released in August, reportedRevenueandEarningsgrowth and a series of new contracts.

On 2 October 2026, PYC shares were trading at $2.46, down 1.99%. As a clinical-stage company, PYC does not yet generate product revenue, and its value is largely linked to the progress of itsDrug Developmentprograms.

On 2 October 2026, Regis shares were trading at $4.43, up 1.37%. The company's full-year results, released in August, reportedRevenueandEarningsgrowth, completed acquisitions and an update on room repricing following the new Aged Care Act.

On 2 October 2026, Ryman shares were trading at $1.47, down 1.67%. The company's financial year ends on 31 March, and its first-quarter trading update for FY27 was released in July.

On 2 October 2026, Sonic shares were trading at $18.46, down 0.81%. The company's full-year results, released in August, reportedRevenueandEarningsgrowth in line with guidance.

On 2 October 2026, Summerset shares were trading at $5.76, down 2.70%. The company's half-year results, released in August, covered the six months to 30 June 2026 and included a change to itsDividendpolicy.